Platinum sensitivity of ovarian cancer cells does not influence their ability to induce M2-type macrophage polarization

Molecular mechanisms of drug resistance in ovarian cancer

(2018) Leyla Norouzi-Barough et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis

(2017) Xia Yuan et al.   GYNECOLOGIC ONCOLOGY

Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer

(2017) Jiahui Xu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer

(2017) Pingting Zhou et al.   Molecular Cancer

EMT, CSCs, and drug resistance: the mechanistic link and clinical implications

(2017) Tsukasa Shibue et al.   Nature Reviews Clinical Oncology

EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy

(2017) Issam Chebouti et al.   Oncotarget

Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells

(2017) Maura Sonego et al.   Scientific Reports

Cisplatin induces stemness in ovarian cancer

(2016) Andrew Wiechert et al.   Oncotarget

Bioelectric modulation of macrophage polarization

(2016) Chunmei Li et al.   Scientific Reports

MicroRNA profiling of cisplatin-resistant oral squamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type features

(2016) Ruma Dey Ghosh et al.   Scientific Reports

Phenotypic, Functional, and Plasticity Features of Classical and Alternatively Activated Human Macrophages

(2015) Abdullah A. Tarique et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide

(2015) Marie Genin et al.   BMC CANCER

Macrophages and Therapeutic Resistance in Cancer

(2015) Brian Ruffell et al.   CANCER CELL

Survival of women with cancers of breast and genital organs in Europe 1999–2007: Results of the EUROCARE-5 study

(2015) Milena Sant et al.   EUROPEAN JOURNAL OF CANCER

Ovarian cancer stem cells induce the M2 polarization of macrophages through the PPARγ and NF-κB pathways

(2015) XINCHAO DENG et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Ovarian cancer stem-like cells elicit the polarization of M2 macrophages

(2015) QING ZHANG et al.   Molecular Medicine Reports

Chemoresistance to doxorubicin induces epithelial-mesenchymal transition via upregulation of transforming growth factor β signaling in HCT116 colon cancer cells

(2015) JINPENG LI et al.   Molecular Medicine Reports

APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells

(2015) N Mohell et al.   Cell Death & Disease

Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer

(2015) Maija Hollmén et al.   Scientific Reports

Quantitative histology analysis of the ovarian tumour microenvironment

(2015) Chunyan Lan et al.   Scientific Reports

A Critical Dose of Doxorubicin Is Required to Alter the Gene Expression Profiles in MCF-7 Cells Acquiring Multidrug Resistance

(2015) Shang-Hsun Tsou et al.   PLoS One

Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles

(2015) Xunhao Xiong et al.   Oncotarget

Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression

(2015) Ang Yuan et al.   Scientific Reports

A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer Metastasis

(2014) Shicheng Su et al.   CANCER CELL

Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial–mesenchymal transition in hepatocellular carcinoma

(2014) Qing-Min Fan et al.   CANCER LETTERS

Resveratrol Inhibits Cisplatin-Induced Epithelial-to-Mesenchymal Transition in Ovarian Cancer Cell Lines

(2014) Sébastien Baribeau et al.   PLoS One

Soluble CD163, a Specific Macrophage Activation Marker, is Decreased by Anti-TNF-αAntibody Treatment in Active Inflammatory Bowel Disease

(2014) A. Dige et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies

(2014) Martina McDermott et al.   Frontiers in Oncology

Monocytes/macrophages support mammary tumor invasivity by co-secreting lineage-specific EGFR ligands and a STAT3 activator

(2013) Philip Vlaicu et al.   BMC CANCER

Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment

(2013) E. M. Dijkgraaf et al.   CANCER RESEARCH

Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: Correlation of CD163 expression, cytokine levels and early relapse

(2013) Silke Reinartz et al.   INTERNATIONAL JOURNAL OF CANCER

M2-polarized tumor-associated macrophages promoted epithelial–mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway

(2013) Chao-Ying Liu et al.   LABORATORY INVESTIGATION

Platinum-Sensitive Recurrence in Ovarian Cancer: The Role of Tumor Microenvironment

(2013) Jeremy Chien et al.   Frontiers in Oncology

Epithelial-mesenchymal transition - activating transcription factors - multifunctional regulators in cancer

(2013) Minal Garg   World Journal of Stem Cells

Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice

(2012) A. M. Gil-Bernabe et al.   BLOOD

EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer

(2012) Alexandria M Haslehurst et al.   BMC CANCER

Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors

(2012) Anne-Katrine Bonde et al.   BMC CANCER

Multidrug Resistance-Linked Gene Signature Predicts Overall Survival of Patients with Primary Ovarian Serous Carcinoma

(2012) J.-P. Gillet et al.   CLINICAL CANCER RESEARCH

Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer

(2012) Sergio Marchini et al.   EUROPEAN JOURNAL OF CANCER

Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile

(2011) Ardian Latifi et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Clinical Relevance of Multidrug Resistance Gene Expression in Ovarian Serous Carcinoma Effusions

(2011) Jean-Pierre Gillet et al.   MOLECULAR PHARMACEUTICS

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

(2010) A Singh et al.   ONCOGENE

The basics of epithelial-mesenchymal transition

(2009) Raghu Kalluri et al.   JOURNAL OF CLINICAL INVESTIGATION

The morphological and molecular features of the epithelial-to-mesenchymal transition

(2009) Gema Moreno-Bueno et al.   Nature Protocols